1975
DOI: 10.1016/0006-2952(75)90310-x
|View full text |Cite
|
Sign up to set email alerts
|

The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
40
0

Year Published

1977
1977
2004
2004

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 155 publications
(46 citation statements)
references
References 15 publications
6
40
0
Order By: Relevance
“…Importantly for our study, furafylline had little effect on HRP enzyme activity up to 25 mM. Orally administered methionine or N-acetyl cysteine could also be administered to increase liver GSH levels (McLean and Day, 1975;Aebi and Lauterburg, 1992). This would decrease the susceptibility of the liver to damage by NAPQI by allowing increased amounts of mercapturic acid to be formed, as well as N-acetylcysteine conjugates.…”
Section: Discussionmentioning
confidence: 82%
“…Importantly for our study, furafylline had little effect on HRP enzyme activity up to 25 mM. Orally administered methionine or N-acetyl cysteine could also be administered to increase liver GSH levels (McLean and Day, 1975;Aebi and Lauterburg, 1992). This would decrease the susceptibility of the liver to damage by NAPQI by allowing increased amounts of mercapturic acid to be formed, as well as N-acetylcysteine conjugates.…”
Section: Discussionmentioning
confidence: 82%
“…Oral administration of sufficient acetaminophen to produce plasma levels in the millimolar range would carry the danger of hepatotoxicity. However, it is possible to selectively protect the liver from any toxic effects of acetaminophen by oral administration of GSH precursors such as methionine or N-acetylcysteine 16 that elevate GSH in the liver but not in other tissues. 17 Activation of acetaminophen in the liver may also be reduced by inhibition of liver P450 activity before GDEPT; for example, the mechanistic noncompetitive inhibitor of human CYP1A2, furafylline, 18 could be administered before GDEPT to eliminate hepatic CYP1A2 activity for the duration of the treatment; after plasma furafylline is cleared, the CYP1A2 activity expressed in transfected tumor cells would be unaffected.…”
Section: Discussionmentioning
confidence: 99%
“…The use of methionine (McLean and Day, 1975;Lancet, 1975) has already been shown to have some protective effect with respect to paracetamol toxicity, and it has been postulated that methionine and/or cysteamine (Mrochek et al, 1974) may supplement existing stocks of reduced thiols such as glutathione used within the hepatocyte to neutralise toxic paracetamol products which are produced by cytochrome P450 oxidase. We have no evidence to confirm or refute this theory.…”
Section: Side Effectsmentioning
confidence: 99%
“…It has been demonstrated in animals and man that methionine (McLean and Day, 1975;Mrochek et al, 1974) and cysteamine (Strubelt et al, 1974) may protect against paracetamol-induced liver damage. In this paper we compare the use of cysteamine and amino-acid solutions containing methionine and/or cysteine in acute paracetamol poisoning.…”
mentioning
confidence: 99%